CSIMarket
 


Aeterna Zentaris Inc.  (AEZS)
Other Ticker:  
 

Aeterna Zentaris's Quick Ratio

AEZS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




AEZS Quick Ratio (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Dec 31 2018)
IV. Quarter
0
III. Quarter
0
II. Quarter
Y / Y Current Liabilities Change -2.29 % 25.48 % - - -
Y / Y Cash & cash equivalent Change -25.15 % -33.28 % - - -
Quick Ratio MRQ 1.99 1.38 2.59 2.59 2.59
Overall Ranking # # # # #
Seq. Current Liabilities Change -22.13 % 25.48 % 0 % 0 % 0 %
Seq. Cash & cash equivalent Change 12.18 % -33.28 % 0 % 0 % 0 %



Quick Ratio third quarter 2019 Comment
Aeterna Zentaris's Cash & cash equivalent grew by 12.18 % in III. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Aeterna Zentaris's Quick Ratio to 1.99, Quick Ratio remained below Aeterna Zentaris Inc. average.

Within Major Pharmaceutical Preparations industry 187 other companies have achieved higher Quick Ratio than Aeterna Zentaris in third quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are AEZS Segments?
See Quick Ratio AEZS on the trailing twelve month basis
Quick Ratio third quarter 2019 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 188
Healthcare Sector # 425
Overall Market # 959


Quick Ratio Statistics
High Average Low
2.59 2.29 1.38
(Dec 31 2018)   (Jun 30 2019)




Financial Statements
Aeterna Zentaris's Current Liabilities $ 5 Millions Visit AEZS's Balance sheet
Aeterna Zentaris's Cash & cash equivalent $ 11 Millions Visit AEZS's Balance sheet
Source of AEZS's Sales Visit AEZS's Sales by Geography




Companies with similar Quick Ratio in the quarter endingSep 30 2019, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2019 MRQ Cash & cash equivalentSep 30 2019 MRQ Current Liabilities
Conatus Pharmaceuticals Inc.  5.45 $ 22.682  Millions$ 4.159  Millions
Millendo Therapeutics, Inc.  5.44 $ 47.151  Millions$ 8.664  Millions
Verastem, Inc.  5.32 $ 160.228  Millions$ 30.131  Millions
Nabriva Therapeutics Plc  5.26 $ 78.276  Millions$ 14.884  Millions
Spectrum Pharmaceuticals Inc  5.18 $ 247.762  Millions$ 47.794  Millions
Intercept Pharmaceuticals, inc.  5.15 $ 720.576  Millions$ 139.974  Millions
Zafgen, Inc.  5.02 $ 82.006  Millions$ 16.339  Millions
Agios Pharmaceuticals, Inc.  4.89 $ 451.897  Millions$ 92.432  Millions
Alnylam Pharmaceuticals, Inc.  4.88 $ 1,721.058  Millions$ 352.864  Millions
Syros Pharmaceuticals, Inc.  4.82 $ 108.776  Millions$ 22.570  Millions
Genprex, Inc.  4.74 $ 2.548  Millions$ 0.537  Millions
Beigene, Ltd.  4.69 $ 1,246.190  Millions$ 265.734  Millions
Marinus Pharmaceuticals Inc  4.65 $ 39.889  Millions$ 8.571  Millions
Cellectar Biosciences, Inc.  4.47 $ 13.302  Millions$ 2.978  Millions
Prophase Labs, Inc.  4.41 $ 4.728  Millions$ 1.073  Millions
Merrimack Pharmaceuticals Inc  4.40 $ 20.858  Millions$ 4.739  Millions
Immunic, Inc.  4.33 $ 30.460  Millions$ 7.036  Millions
Phio Pharmaceuticals Corp.  4.28 $ 8.709  Millions$ 2.036  Millions
Catalyst Pharmaceuticals, Inc.  4.26 $ 76.545  Millions$ 17.982  Millions
Esperion Therapeutics, inc.  4.24 $ 243.861  Millions$ 57.518  Millions
Tonix Pharmaceuticals Holding Corp.  4.24 $ 10.024  Millions$ 2.366  Millions
Neubase Therapeutics, Inc.  4.12 $ 10.314  Millions$ 2.502  Millions
Rezolute, Inc.  4.01 $ 22.139  Millions$ 5.523  Millions
Recro Pharma, Inc.  3.96 $ 37.944  Millions$ 9.573  Millions
Xoma Corp  3.94 $ 39.744  Millions$ 10.089  Millions
Ptc Therapeutics, inc.  3.86 $ 708.649  Millions$ 183.500  Millions
Shineco, Inc.  3.76 $ 37.613  Millions$ 9.997  Millions
Sunesis Pharmaceuticals Inc  3.69 $ 32.813  Millions$ 8.894  Millions
Ovid Therapeutics Inc.  3.67 $ 38.021  Millions$ 10.361  Millions
Kyto Technology & Life Science, Inc.  3.61 $ 0.238  Millions$ 0.066  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EXPCU's Profile

Stock Price

EXPCU's Financials

Business Description

Fundamentals

Charts & Quotes

EXPCU's News

Suppliers

EXPCU's Competitors

Customers & Markets

Economic Indicators

EXPCU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071